Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 2024-09-02 08:23
ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™ 2024-08-31 00:30
LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8% 2024-08-30 20:48
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 2024-08-30 20:44
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China 2024-08-30 19:34
Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line 2024-08-30 18:00
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations 2024-08-30 11:01
/DISREGARD RELEASE: Celltrion USA/ 2024-08-30 08:35
CARsgen® Announces 2024 Interim Results 2024-08-29 20:50
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms 2024-08-29 20:42
Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts 2024-08-29 20:30
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics 2024-08-29 20:30
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions 2024-08-29 20:00
Discover the Top 6 Highlights of Medtec 2024 and Explore the Latest Industry Trends 2024-08-29 17:00
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results 2024-08-29 14:31
Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan 2024-08-29 13:38
Smartee Hosts Breakthrough GS Mandibular Repositioning Therapy Conference in Singapore 2024-08-29 12:47
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital 2024-08-29 10:00
Necessary Care or Abuse? Unpacking the Reason Behind Overprescription 2024-08-29 08:30
Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 2024-08-29 08:00
1 31 32 33 34 35 962